Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CMS Finalizes Spending Per Beneficiary Quality Measure Over MDMA Objections

Executive Summary

The US Medicare agency in its final 2019 Inpatient Prospective Payment System rule plans to continue assessing patients’ outcomes under its Hospital Value-Based Program in part with a Medicare spending per beneficiary measure, despite industry warnings that doing so may sacrifice patient quality of care.

Advertisement

Related Content

Three Devices Gain Medicare Add-Ons, Including Boston Sci's New TAVR Protector

Topics

Advertisement
UsernamePublicRestriction

Register

MT123113

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel